Benzinga | Mar 16, 2021 10:37AM EDT

Canaccord Genuity Downgrades GenMark Diagnostics to Hold

Canaccord Genuity analyst Max Masucci downgrades GenMark Diagnostics (NASDAQ:GNMK) from Buy to Hold.